GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.2050
-0.0273 (-11.75%)
At close: Mar 28, 2025, 4:00 PM
0.1801
-0.0249 (-12.15%)
After-hours: Mar 28, 2025, 7:58 PM EDT
GlucoTrack Employees
GlucoTrack had 6 employees as of December 31, 2023. The number of employees increased by 3 or 100.00% compared to the previous year.
Employees
6
Change (1Y)
3
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,485,833
Market Cap
2.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GCTK News
- 11 days ago - Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - GlobeNewsWire
- 4 weeks ago - Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member - GlobeNewsWire
- 7 weeks ago - Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 2 months ago - Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer - GlobeNewsWire
- 2 months ago - Glucotrack Announces ISO 13485:2016 Certification - GlobeNewsWire
- 2 months ago - Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs - GlobeNewsWire
- 2 months ago - Glucotrack to Present at TechBio Showcase™ 2025 - GlobeNewsWire